Physician profile
Thomas Lane Bernasek
NPI 1881699726
$6,355,070.33
in general payments reported to CMS, 2019-2025
21 companies · $685K in 2025
The $685K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.4M · 2020: $943K · 2021: $1.1M · 2022: $807K · 2023: $745K · 2024: $644K · 2025: $685K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.0M · Consulting Fee: $42K · Travel and Lodging: $2,758 · Food and Beverage: $2,454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,027,148.27 |
| Consulting Fee | $41,998.75 |
| Travel and Lodging | $2,757.50 |
| Food and Beverage | $2,454.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $6,033,465.65 | 2019-2025 | Attune |
| Medical Device Business Services, INC. | $313,602.12 | 2019-2025 | Attune, Kincise, Velys |
| Corin USA | $2,703.13 | 2019 | |
| Depuy Synthes Sales INC. | $1,018.47 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $815.12 | 2019-2024 | Persona, Mymobility Platform |
| Stryker Corporation | $641.14 | 2019-2025 | Mako, Triathlon |
| Innovation Technologies INC | $477.03 | 2020-2025 | Irrisept |
| Sanara Medtech INC. | $329.24 | 2023-2025 | Celleraterx, Biasurge |
| Linkbio Corp | $314.43 | 2021-2024 | |
| Solventum Corporation | $254.96 | 2024-2025 | Prevena, V.A.C.Ulta |
| Smith+Nephew, INC. | $235.56 | 2025 | Pico 14 |
| Omnilife Science, INC | $189.22 | 2021 | |
| Alphatec Spine, INC | $175.22 | 2022 | |
| Next Science LLC | $160.10 | 2021-2023 | Surgx, Blastx, Xperience |
| Peter Brasseler Holdings, LLC | $128.18 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $124.95 | 2024 | Zynrelef |
| Vericel Corporation | $121.31 | 2020 | |
| Biocomposites INC | $114.75 | 2019 | |
| Illuminoss Medical, INC. | $102.11 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Kci USA, INC. | $85.70 | 2023 | Prevena |
| Ethicon US, LLC | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bernasek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.